SORD antibody
Principal name
SORD antibody
Alternative names for SORD antibody
Sorbitol dehydrogenase, L-iditol 2-dehydrogenase
SwissProt ID
P07846 (Sheep), P27867 (Rat), P36624 (Schpo), Q00796 (Human), Q29318 (Pig), Q58D31 (Bovin), Q64442 (Mouse)
Ncbi ID
9606, NP_003095, AAH25295, 9940, NM_003104, NP_003095.2, NP_666238.1, NM_146126, NM_017052
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), Paraffin Sections (P), ELISA (detection) (E(detection)), EPair for Elisa (EPair), Dot blot (Dot), Immunodiffusion (ID), Immunocytochemistry/Immunofluorescence (ICC/IF), Immunoprecipitation (IP), Radioimmunoassay (R), Flow Cytometry (F)
Background of SORD antibody
- Kit Component:
- - KN316475G1, Sord gRNA vector 1 in pCas-Guide vector
- KN316475G2, Sord gRNA vector 2 in pCas-Guide vector
- KN316475D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Karacaoglan V, Ozer I. Steady-state kinetic properties of sorbitol dehydrogenase from chicken liver. Comp Biochem Physiol B Biochem Mol Biol. 2005 Feb;140(2):309-12.
Immunoperoxidase of monoclonal antibody to SORD on formalin-fixed paraffin-embedded human kidney. [antibody concentration 1.2 ug/ml]
Western Blot analysis of SORD expression in transfected 293T cell line by SORD monoclonal antibody (M01), clone 4D3.Lane 1: SORD transfected lysate(38.165 KDa).Lane 2: Non-transfected lysate.
SORD monoclonal antibody (M01), clone 4D3. Western Blot analysis of SORD expression in PC-12 ( Cat # L012V1 ).
SORD monoclonal antibody (M01), clone 4D3. Western Blot analysis of SORD expression in NIH/3T3 ( Cat # L018V1 ).
SORD monoclonal antibody (M01), clone 4D3. Western Blot analysis of SORD expression in Raw 264.7 ( Cat # L024V1 ).
SORD monoclonal antibody (M01), clone 4D3 Western Blot analysis of SORD expression in Hela NE ( Cat # L013V3 ).
Detection limit for recombinant GST tagged SORD is approximately 0.1ng/ml as a capture antibody.
SORD polyclonal antibody (A01), Lot # 051123JC01 Western Blot analysis of SORD expression in HL-60 ( Cat # L014V1 ).
SORD polyclonal antibody ( Cat # PAB6726 ) ( 0.1 µg/ml ) staining of Mouse kidney lysate ( 35 µg protein in RIPA buffer ) . Primary incubation was 1 hour. Detected by chemiluminescence.
Detection limit for recombinant GST tagged SORD is approximately 0.1ng/ml as a capture antibody.
Western Blot analysis of SORD expression in transfected 293T cell line (H00006652-T01) by SORD MaxPab polyclonal antibody.Lane 1: SORD transfected lysate(38.30 KDa).Lane 2: Non-transfected lysate.
Immunoperoxidase of purified MaxPab antibody to SORD on formalin-fixed paraffin-embedded human prostate. [antibody concentration 3 ug/ml]
SORD MaxPab polyclonal antibody. Western Blot analysis of SORD expression in human liver.
Western Blot analysis of SORD expression in transfected 293T cell line (H00006652-T02) by SORD MaxPab polyclonal antibody.Lane 1: SORD transfected lysate(39.27 KDa).Lane 2: Non-transfected lysate.
SORD MaxPab polyclonal antibody. Western Blot analysis of SORD expression in Jurkat.
Recombinant human SORD, 1-357 aa, His-tagged
Human HeLa; WB Suggested Anti-SORD Antibody. . Titration: 1.0 ug/ml. . Positive Control: Hela Whole Cell. SORD is strongly supported by BioGPS gene expression data to be expressed in Human HeLa cells.; SORD antibody - N-terminal region (ARP61128_P050) in Human HeLa cells using Western Blot
Western blot analysis of SORD Antibody (Center) Cat.-No AP53985PU-N in Hela cell line lysates (35ug/lane).This demonstrates the SORD antibody detected the SORD protein (arrow).
The cell lysates of Jurkat (40ug) were resolved by SDS-PAGE, transferred to PVDF membrane and probed with anti-human SORD antibody (1:1000). Proteins were visualized using a goat anti-mouse secondary antibody conjugated to HRP and an ECL detection system.
Immunohistochemical staining of paraffin-embedded Kidney tissue within the normal limits using anti-SORDmouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA500677, Dilution 1:50)
Immunohistochemical staining of paraffin-embedded colon tissue within the normal limits using anti-SORDmouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA500677, Dilution 1:50)
Immunohistochemical staining of paraffin-embedded breast tissue within the normal limits using anti-SORD mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA500677, Dilution 1:50)
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of colon tissue using anti-SORDmouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA500677, Dilution 1:50)
Immunohistochemical staining of paraffin-embedded Carcinoma of thyroid tissue using anti-SORDmouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA500677, Dilution 1:50)
Immunohistochemical staining of paraffin-embedded Ovary tissue within the normal limits using anti-SORDmouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA500677, Dilution 1:50)
Immunohistochemical staining of paraffin-embedded pancreas tissue within the normal limits using anti-SORDmouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA500677, Dilution 1:50)
Immunohistochemical staining of paraffin-embedded Carcinoma of bladder tissue using anti-SORDmouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA500677, Dilution 1:50)
Immunohistochemical staining of paraffin-embedded endometrium tissue within the normal limits using anti-SORDmouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA500677, Dilution 1:50)
Immunohistochemical staining of paraffin-embedded prostate tissue within the normal limits using anti-SORDmouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA500677, Dilution 1:50)
Western blot analysis of extracts (35ug) from 9 different cell lines by using anti-SORD monoclonal antibody.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SORD (RC200415, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SORD.
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of ovary tissue using anti-SORDmouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA500683, Dilution 1:50)
Immunohistochemical staining of paraffin-embedded Ovary tissue within the normal limits using anti-SORDmouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA500683, Dilution 1:50)
Immunohistochemical staining of paraffin-embedded endometrium tissue within the normal limits using anti-SORDmouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA500683, Dilution 1:50)
Immunohistochemical staining of paraffin-embedded colon tissue within the normal limits using anti-SORDmouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA500683, Dilution 1:50)
Immunohistochemical staining of paraffin-embedded pancreas tissue within the normal limits using anti-SORDmouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA500683, Dilution 1:50)
Immunoprecipitation(IP) of SORD by using TrueMab monoclonal anti-SORD antibodies (Negative control: IP without adding anti-SORD antibody.). For each experiment, 500ul of DDK tagged SORD overexpression lysates (at 1:5 dilution with HEK293T lysate), 2ug of
Western blot analysis of extracts (35ug) from 9 different cell lines by using anti-SORD monoclonal antibody.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SORD (RC200415, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SORD.
Immunohistochemical staining of paraffin-embedded liver tissue within the normal limits using anti-SORDmouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA500701, Dilution 1:50)
Immunohistochemical staining of paraffin-embedded thyroid tissue within the normal limits using anti-SORDmouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA500701, Dilution 1:50)
Immunohistochemical staining of paraffin-embedded breast tissue within the normal limits using anti-SORD mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA500701, Dilution 1:50)
Immunohistochemical staining of paraffin-embedded prostate tissue within the normal limits using anti-SORDmouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA500701, Dilution 1:50)
Immunohistochemical staining of paraffin-embedded Kidney tissue within the normal limits using anti-SORDmouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA500701, Dilution 1:50)
Immunohistochemical staining of paraffin-embedded endometrium tissue within the normal limits using anti-SORDmouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA500701, Dilution 1:50)
Immunofluorescent staining of HepG2 cells using anti-SORD mouse monoclonal antibody (TA500701).
Anti-SORD mouse monoclonal antibody (TA500701) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY SORD(RC200415).
Western blot analysis of extracts (35ug) from 9 different cell lines by using anti-SORD monoclonal antibody.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SORD (RC200415, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SORD.
Flow cytometric analysis of Jurkat cells, using anti-SORD antibody(TA500701),(Red) compared to a nonspecific negative control antibody(TA50011)(Blue).
Flow cytometric analysis of Hela cells, using anti-SORD antibody(TA500701),(Red) compared to a nonspecific negative control antibody(TA50011)(Blue).
HEK293T cells transfected with either pCMV6-ENTRY SORD(RC200415)(Red) or empty vector control plasmid(Blue) were immunostained with anti-SORD mouse monoclonal(TA500701, Dilution 1:1,000), and then analyzed by flow cytometry.
Immunofluorescent staining of HepG2 cells using anti-SORD mouse monoclonal antibody (TA500702).
Anti-SORD mouse monoclonal antibody (TA500702) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY SORD(RC200415).
Western blot analysis of extracts (35ug) from 9 different cell lines by using anti-SORD monoclonal antibody (HepG2: human; HeLa: human; SVT2: mouse; A549: human; COS7: monkey; Jurkat: human; MDCK: canine; PC12: rat; MCF7: human).(1:200)
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SORD (RC200415, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SORD.
Flow cytometric analysis of Hela cells, using anti-SORD antibody(TA500702),(Red) compared to a nonspecific negative control antibody(TA50011)(Blue).
Flow cytometric analysis of Jurkat cells, using anti-SORD antibody(TA500702),(Red) compared to a nonspecific negative control antibody(TA50011)(Blue).
HEK293T cells transfected with either pCMV6-ENTRY SORD(RC200415)(Red) or empty vector control plasmid(Blue) were immunostained with anti-SORD mouse monoclonal(TA500702, Dilution 1:1,000), and then analyzed by flow cytometry.
Immunohistochemical staining of paraffin-embedded colon tissue within the normal limits using anti-SORDmouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA500747, Dilution 1:50)
Immunohistochemical staining of paraffin-embedded endometrium tissue within the normal limits using anti-SORDmouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA500747, Dilution 1:50)
Immunohistochemical staining of paraffin-embedded breast tissue within the normal limits using anti-SORD mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA500747, Dilution 1:50)
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of colon tissue using anti-SORDmouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA500747, Dilution 1:50)
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of breast tissue using anti-SORD mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA500747, Dilution 1:50)
Immunohistochemical staining of paraffin-embedded pancreas tissue within the normal limits using anti-SORDmouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA500747, Dilution 1:50)
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of ovary tissue using anti-SORDmouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA500747, Dilution 1:50)
Immunohistochemical staining of paraffin-embedded bladder tissue within the normal limits using anti-SORDmouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA500747, Dilution 1:50)
Immunohistochemical staining of paraffin-embedded thyroid tissue within the normal limits using anti-SORDmouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA500747, Dilution 1:50)
Immunohistochemical staining of paraffin-embedded prostate tissue within the normal limits using anti-SORDmouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA500747, Dilution 1:50)
Immunohistochemical staining of paraffin-embedded Carcinoma of pancreas tissue using anti-SORDmouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA500747, Dilution 1:50)
Immunohistochemical staining of paraffin-embedded Carcinoma of prostate tissue using anti-SORDmouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA500747, Dilution 1:50)
Immunohistochemical staining of paraffin-embedded Carcinoma of bladder tissue using anti-SORDmouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA500747, Dilution 1:50)
Western blot analysis of extracts (35ug) from 9 different cell lines by using anti-SORD monoclonal antibody (HepG2: human; HeLa: human; SVT2: mouse; A549: human; COS7: monkey; Jurkat: human; MDCK: canine; PC12: rat; MCF7: human).(1:200)
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SORD (RC200415, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SORD.
Flow cytometric analysis of Hela cells, using anti-SORD antibody(TA500747),(Red) compared to a nonspecific negative control antibody(TA50011)(Blue).
Flow cytometric analysis of Jurkat cells, using anti-SORD antibody(TA500747),(Red) compared to a nonspecific negative control antibody(TA50011)(Blue).
Immunofluorescent staining of HepG2 cells using anti-SORD mouse monoclonal antibody (TA500748).
Anti-SORD mouse monoclonal antibody (TA500748) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY SORD(RC200415).
HEK293T cells transfected with either pCMV6-ENTRY SORD(RC200415)(Red) or empty vector control plasmid(Blue) were immunostained with anti-SORD mouse monoclonal(TA500748), and then analyzed by flow cytometry.
Flow cytometric analysis of Jurkat cells, using anti-SORD antibody(TA500748),(Red) compared to a nonspecific negative control antibody(TA50011)(Blue).
Flow cytometric analysis of Hela cells, using anti-SORD antibody(TA500748),(Red) compared to a nonspecific negative control antibody(TA50011)(Blue).
Anti-SORD mouse monoclonal antibody (TA500749) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY SORD(RC200415).
HEK293T cells transfected with either pCMV6-ENTRY SORD(RC200415)(Red) or empty vector control plasmid(Blue) were immunostained with anti-SORD mouse monoclonal(TA500749), and then analyzed by flow cytometry.
Immunohistochemical staining of paraffin-embedded endometrium tissue within the normal limits using anti-SORDmouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA500784, Dilution 1:50)
Immunohistochemical staining of paraffin-embedded Ovary tissue within the normal limits using anti-SORDmouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA500784, Dilution 1:50)
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SORD (RC200415, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SORD.
Anti-SORD mouse monoclonal antibody (TA500785) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY SORD(RC200415).
HEK293T cells transfected with either pCMV6-ENTRY SORD(RC200415)(Red) or empty vector control plasmid(Blue) were immunostained with anti-SORD mouse monoclonal(TA500785), and then analyzed by flow cytometry.
Flow cytometric analysis of Jurkat cells, using anti-SORD antibody(TA500785),(Red) compared to a nonspecific negative control antibody(TA50011)(Blue).
Flow cytometric analysis of Hela cells, using anti-SORD antibody(TA500785),(Red) compared to a nonspecific negative control antibody(TA50011)(Blue).
TA302618 (0.1µg/ml) staining of Mouse Kidney lysate (35µg protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.
Predicted band size: 38 kDa . Positive control: HeLa cell lysate. Recommended dilution: 1/500-2000. (Gel: 10%SDS-PAGE Lysate: 40 ug Primary antibody: 1/500 dilution Secondary antibody: Goat anti Rabbit IgG - H&L (HRP) at 1/10000 dilution Exposure time: 1 minute)
Western blot analysis of extracts of various cell lines, using SORD antibody.
Immunohistochemistry of paraffin-embedded rat lung using SORD antibody at dilution of 1:200 (200x lens).
Immunofluorescence analysis of MCF7 cell using SORD antibody. Blue: DAPI for nuclear staining.
- Quick-Filters:
- Highly Validated (7)
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA500677 | SORD antibody |
||||||
| anti-SORD (Sorbitol Dehydrogenase) mouse monoclonal antibody, clone OTI12A7 (formerly 12A7) | |||||||
 |
Mouse | IgG1 | OTI12A7 | Purified | Hu | P, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
 +11 additional images |
Highly validated antibody!
|
||||||
| TA500683 | SORD antibody |
||||||
| anti-SORD (Sorbitol Dehydrogenase) mouse monoclonal antibody, clone OTI2A10 (formerly 2A10) | |||||||
 |
Mouse | IgG2b | OTI2A10 | Purified | Hu | P, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +7 additional images |
Highly validated antibody!
|
||||||
| TA500701 | SORD antibody |
||||||
| anti-SORD (Sorbitol Dehydrogenase) mouse monoclonal antibody, clone OTI9E7 (formerly 9E7) | |||||||
 |
Mouse | IgG2a | OTI9E7 | Purified | Hu | F, ICC/IF, P, WB |
0.1 ml /
€379.00
|
| OriGene Technologies, Inc. | |||||||
| +12 additional images |
Highly validated antibody!
|
||||||
| TA500702 | SORD antibody |
||||||
| anti-SORD (Sorbitol Dehydrogenase) mouse monoclonal antibody, clone OTI1D5 (formerly 1D5) | |||||||
 |
Mouse | IgG2a | OTI1D5 | Purified | Hu | F, ICC/IF, P, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +12 additional images |
Highly validated antibody!
|
||||||
| TA500747 | SORD antibody |
||||||
| anti-SORD (Sorbitol Dehydrogenase) mouse monoclonal antibody, clone OTI15H2 (formerly 15H2) | |||||||
 |
Mouse | IgG1 | OTI15H2 | Purified | Hu | F, P, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +16 additional images |
Highly validated antibody!
|
||||||
| TA500748 | SORD antibody |
||||||
| anti-SORD (Sorbitol Dehydrogenase) mouse monoclonal antibody, clone OTI17E7 (formerly 17E7) | |||||||
 |
Mouse | IgG1 | OTI17E7 | Purified | Hu | F, ICC/IF |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +4 additional images |
Highly validated antibody!
|
||||||
| TA500785 | SORD antibody |
||||||
| anti-SORD (Sorbitol Dehydrogenase) mouse monoclonal antibody, clone OTI9G9 (formerly 9G9) | |||||||
 |
Mouse | IgG1 | OTI9G9 | Purified | Hu | F, ICC/IF |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +3 additional images |
Highly validated antibody!
|
||||||
| TA302618 | SORD (C-term) antibody |
||||||
| Goat Polyclonal Antibody against Sorbitol Dehydrogenase | |||||||
 |
Goat | Aff - Purified | Can, Chk, Hu, Ms, Rt | WB |
0.1 mg /
€360.00
|
||
| OriGene Technologies, Inc. | |||||||
| TA321558 | SORD antibody |
||||||
| Anti-SORD Rabbit Polyclonal Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| TA327281 | SORD antibody |
||||||
| Rabbit anti-SORD Polyclonal Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt |
0.1 mg /
€335.00
|
||
| OriGene Technologies, Inc. | |||||||
| +2 additional images |
|||||||
| TA500749 | SORD antibody |
||||||
| anti-SORD (Sorbitol Dehydrogenase) mouse monoclonal antibody, clone OTI4E5 (formerly 4E5) | |||||||
 |
Mouse | IgG3 | OTI4E5 | Purified | Hu | F, ICC/IF |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|
||||||
| TA500784 | SORD antibody |
||||||
| anti-SORD (Sorbitol Dehydrogenase) mouse monoclonal antibody, clone OTI13G5 (formerly 13G5) | |||||||
 |
Mouse | IgG1 | OTI13G5 | Purified | Hu | P, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +2 additional images |
|
||||||
| AM50068PU-N | SORD antibody |
||||||
 |
Mouse | IgG1 | AT10F4 | Purified | Hu | E, WB |
0.1 ml /
€330.00
|
| OriGene Technologies GmbH | |||||||
| AM50068PU-S | SORD antibody |
||||||
|
Mouse | IgG1 | AT10F4 | Purified | Hu | E, WB |
50 µl /
€220.00
|
| OriGene Technologies GmbH | |||||||
| AP53985PU-N | SORD (Center) antibody |
||||||
 |
Rabbit | Ig | Aff - Purified | Hu | WB |
0.4 ml /
€415.00
|
|
| OriGene Technologies GmbH | |||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP300415 | SORD |
||||
| Recombinant protein of human sorbitol dehydrogenase (SORD) | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY401082 | SORD overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR205452L2V | Lenti ORF particles, Sord (GFP-tagged) - Mouse sorbitol dehydrogenase (Sord), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR205452L1V | Lenti ORF particles, Sord (Myc-DDK-tagged) - Mouse sorbitol dehydrogenase (Sord), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||
Rat Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RR205384L2V | Lenti ORF particles, Sord (GFP-tagged ORF) - Rat sorbitol dehydrogenase (Sord), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||